TY - JOUR AU - Hickey, Kathleen T. AU - Hauser, Nicole R. AU - Valente, Laura E. AU - Riga, Teresa C. AU - Frulla, Ashton P. AU - Creber, Ruth Masterson AU - Whang, William AU - Garan, Hasan AU - Jia, Haomiao AU - Sciacca, Robert R. AU - Wang, Daniel Y. PY - 2016 DA - 2016/07/16 TI - A single-center randomized, controlled trial investigating the efficacy of a mHealth ECG technology intervention to improve the detection of atrial fibrillation: the iHEART study protocol JO - BMC Cardiovascular Disorders SP - 152 VL - 16 IS - 1 AB - Atrial fibrillation is a major public health problem and is the most common cardiac arrhythmia, affecting an estimated 2.7 million Americans. The true prevalence of atrial fibrillation is likely underestimated because episodes are often sporadic; therefore, it is challenging to detect and record an occurrence in a “real world” setting. To date, mobile health tools that promote earlier detection and treatment of atrial fibrillation and improvement in self-management behaviors and knowledge have not been evaluated. This study will be the first to address the epidemic problem of atrial fibrillation with a novel approach utilizing advancements in mobile health electrocardiogram technology to empower patients to actively engage in their healthcare and to evaluate impact on quality of life and quality-adjusted life years. Furthermore, sending a daily electrocardiogram transmission, coupled with receiving educational and motivational text messages aimed at promoting self-management and a healthy lifestyle may improve the management of chronic cardiovascular conditions (e.g., hypertension, diabetes, heart failure, etc.). Therefore, we are currently conducting a randomized controlled trial to assess the efficacy of a mobile health intervention, iPhone® Helping Evaluate Atrial fibrillation Rhythm through Technology (iHEART) versus usual cardiac care. SN - 1471-2261 UR - https://doi.org/10.1186/s12872-016-0327-y DO - 10.1186/s12872-016-0327-y ID - Hickey2016 ER -